You are here: Industry Insights > AMR

News List

Novel antibiotic Recarbrio has launched in the UK pharmatimes
November 20, 2020
MSD’s novel antibiotic treatment Recarbrio has launched in the UK as concerns grow over the rise of antimicrobial resistance (AMR) globally.
How the AMR Action Fund intends to support antibiotic-focused biotechs expresspharma
July 24, 2020
While focus is on the global deaths from COVID-19 crossing the six lakh mark, we have lost seven lakh people to antimicrobial resistance (AMR) each year, which is why more than 20 biopharmaceutical companies recently announced the launch of the AMR ...
Global antimicrobial resistance fund to support development of innovative antibiotics europeanpharmaceuticalreview
July 17, 2020
The fund has already raised $1 billion to support clinical research of novel antibiotics and intends to bring up to four new antibiotics to market by 2030.
Drugmakers partner to launch $1bn fund for antibiotics development pharmaceutical-technology
July 13, 2020
More than 20 major biopharmaceutical companies, including Pfizer, GlaxoSmithKline and Johnson & Johnson, have partnered to launch the AMR Action Fund with an aim to provide two to four new antibiotics to patients by 2030.
Evolving World of Pharma: AMR-pushing healthcare back in time Sarah Harding
December 13, 2019
Most of us take for granted the ability to fight infections that, less than a century ago, could have caused severe illness, disfigurement or death.
BioVersys Receives CARB-X Award of up to US$ 8.92 Million for Development of Novel Antimicrobial Therapies b3cnewswire
October 30, 2019
BioVersys AG, a privately owned, multi-asset Swiss pharmaceutical company focusing on research and development of small molecules for multidrug-resistant bacterial infections with applications in ...
AMR could cause 10 million deaths per year by 2050 pharmatimes
May 09, 2019
A new UN report has shown that if left unchecked, antimicrobial resistance (AMR) could cause as many as 10 million deaths per year by 2050.
Gov’t offers £56m for research into public health challenges pharmatimes
March 12, 2019
Health Minister Nicola Blackwood has announced up to £56 million funding for research into the biggest challenges facing public health - climate change, air pollution, antimicrobial resistance and global pandemics.
Probiotic Sanitation Cuts Antimicrobial Resistance in Hospitals drugs
March 08, 2019
An environmental intervention of probiotic sanitation can effectively alter hospital microbiota, helping to limit the spread of antimicrobial resistance (AMR) in health care-associated infections (HAIs), according to a study published online Feb. 27 in In
Novo Holdings invests in three more AMR biotechs pharmaphorum
January 23, 2019
Novo Holdings’ REPAIR Impact Fund, which helps fund companies tackling antimicrobial resistance (AMR), has announced three new investments....

Previous page 1 2 3 Next page